Literature DB >> 1245740

Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

R H Zubler, G Lange, P H Lambert, P A Miescher.   

Abstract

The 125I-Clq binding test was modified in order to allow for the detection of immune complexes in native unheated human serum. Indeed, heat-inactivation (56 degrees, 30 min) was found to reduce the Clq-binding activity of immune complexes mixed with native serum. This effect was not observed when EDTA was added to the native serum before mixing the immune complexes. The modified 125I-Clq binding test was performed in two steps: first, the tested native serum sample was incubated for 30 min at 37 degrees C with 0.13 M EDTA in order to prevent the integration of 125I-Clq into the intrinsic Clqrs complex, second, 125I-Clq and polyethylene glycol (final concentration 2.5%) were added to this mixture, and further incubated for 1 hr at 4 degrees C. Under these conditions, free Clq remained soluble whereas Clq bound to macromolecular complexes was precipitated. The competitive effect of intrinsic Clq and the interference of other substances such as DNA or bacterial LPS were very limited. The modified Clq binding test was applied to the clinical investigation of 44 patients with systemic lupus erythematosus; and increased Clq binding activity (Clq-BA) was observed in 91% of the samples. The level of Clq-BA was found to be significantly correlated to the DNA-binding capacity and to the decrease of the level of some complement components.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245740

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  232 in total

1.  Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.

Authors:  G Füst; G A Medgyesi; E Rajnavölgyi; M Csécsi-Nagy; K Czikora; J Gergely
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Rat spleen leucocyte (RSL) radioimmunoassay for the detection and quantification of soluble immune complexes.

Authors:  S F Al-Khateeb; T Barkas
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

3.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.

Authors:  P B Krauledat; F E Krapf; B Manger; J R Kalden
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Intralesional plasma cells and serological responses in human cutaneous leishmaniasis.

Authors:  P L Moriearty; G Grimaldi; B Galvão-Castro; M P de Oliveira Neto; M C Marzochi
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Enhancement of in situ immune complex formation in isolated perfused kidneys in Heymann's nephritis.

Authors:  S P Makker; I J Kirson; B Moorthy
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  Does insulin administration contribute to immune complex formation in diabetes?

Authors:  L V Campbell; J A Charlesworth; G V Pasterfield; A Jenkins; B A Pussell
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

10.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.